RAIDEN RESOURCES LIMITED — Capital/Financing Update 2006

Dec 6, 2006

6 December 2006

Company Announcements Office Australian Stock Exchange Ltd Sydney 2000

RE: Private Placement of Shares (ASX:MDM)

The Directors are pleased to announce that a Private Placement of 8,069,736 Fully Paid Ordinary Shares has been completed. This placement is part of the available allotment of shares as approved by Shareholders at the EGM of 31 August, 2006.

A total of \$1,573,600 has been raised at \$0.195 per share in the placement.

As previously announced, the funds are being used for the final settlement of the Brisbane River Terraces, and in the purchase of the Ashmond Villas Cooroy, over50's health and lifestyle village.

The Directors believe that this transaction will greatly benefit the Company, through an increased and secure revenue stream, and for all shareholders over the long term.

Dr Allan Shell Managing Director

Medical Monitors Limited Suite 407 Office Tower Westfield Eastgardens Eastgardens NSW 2036 Australia Tel 02 9344 8100 Fax 02 9344 8200

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002.

Name of entity

Medical Monitors Limited

ABN

68 009 161 522

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf{1}$ ⁺Class of ⁺securities issued or to be issued

Ordinary Shares

• $\mathcal{D}$ Number of $*$ securities issued or to be issued (if known) or maximum number which may be issued
• Principal terms of the ⁺securities (eg, 3 if options, exercise price and expiry date; if partly paid 'securities, the amount outstanding and due dates for payment; if ⁺convertible securities, the conversion price and dates for conversion)

8,069,736

Fully paid

⁺ See chapter 19 for defined terms.

Do the 'securities rank equally in all $Y_{\rm es}$ $\overline{A}$ respects from the date of allotment with an existing 'class of quoted *securities?

If the additional securities do not rank equally, please state:

• $\bullet$ the date from which they do
• $\bullet$ the extent to which they participate for the next dividend. (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
• $\overline{5}$ Issue price or consideration
• Purpose of the issue 6 (If issued as consideration for the acquisition of assets, clearly identify those assets)
• Dates of entering ⁺securities into $\overline{\tau}$ uncertificated holdings or despatch of certificates

\$0.195 each

The shares were issued through a private placement of shares to 30 November, 2006, to complete the purchase of the Brisbane River Terraces and the Ashmond Villas Cooroy residential villages (as previously announced, and as approved by Shareholders at the EGM of 31 August, 2006).

30 November, 2006

		Number	+Class
8	Number and + class of all + securities quoted on ASX (including the securities in clause 2 if applicable)	77,753,692	Ordinary Shares (as Reconstructed)

⁺ See chapter 19 for defined terms.

to defer the development of a dividend policy

until surplus cash flows are available.

		Number	+ Class
9	Number and + class of all + securities not quoted on ASX (including the securities in clause 2 if applicable)	3,000,000	Unlisted Options (as reconstructed), exercisable at \$0.20, each expiring 30 June 2007.
10	Dividend policy (in the case of a trust, distribution policy) on the		No dividend policy has been formulated by the company at this stage. It is the Board's intention

Part 2 - Bonus issue or pro rata issue

increased capital (interests)

$\mathbf{1}$	security holder approval N/A Ĭs required?
12	Is the issue renounceable or non- renounceable?
13	Ratio in which the *securities will be offered
14	+ Class of + securities to which the offer relates
15	+Record determine date tσ entitlements
16	Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?
17	Policy for deciding entitlements in relation to fractions
18	Names of countries in which the entity has *security holders who will not be sent new issue documents
	Note: Security holders must be told how their entitlements are to be dealt with.
	Cross reference: rale 7.7.
19	of Closing date for receipt acceptances or renunciations

⁺ See chapter 19 for defined terms.

Appendix 3B New issue announcement

20	Names of any underwriters
21	Amount of any underwriting fee or commission
22.	Names of any brokers to the issue
23.	Fee or commission payable to the broker to the issue
24	Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of 'security holders
25.	If the issue is contingent on *security holders' approval, the date of the meeting
26	Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled
27	If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders
28	Date rights trading will begin (if applicable)
29	Date rights trading will end (if applicable)
30	How do *security holders sell their entitlements in full through a broker?
31	How do *security holders sell part of their entitlements through a broker and accept for the balance?

32 How do ⁺security holders dispose of their entitlements (except by sale through a broker)?

33 *Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of securities $(tick one)$
• Securities described in Part 1 $(a)$ Γx
• $(b)$

All other securities

Example: restricted securities at the end of the eserowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

(If the additional securities do not form a new class, go to $43$ )

Tick to indicate you are providing the information or documents

• 35 If the *securities are *equity securities, the names of the 20 largest holders of the additional *securities, and the number and percentage of additional *securities held by those holders
• If the "securities are "equity securities, a distribution schedule of the additional *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ 10,001 - 100,000
  • 100,001 and over

37

36

A copy of any trust deed for the additional 'securities

(now go to $43$ )

⁺ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

• 38 Number of securities for which ⁺quotation is sought
• Class of ⁺securities for which 39 quotation is sought
• $40$ Do the ⁺securities rank equally in all respects from the date of allotment with an existing 'class of quoted *securities?

If the additional securities do not rank equally, please state:

• the date from which they do
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
• $41$ Reason for request for quotation now

Example: in the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

$42$ Number and ⁺class of all ⁺securities quoted on ASX (including the securities in clause 38)

Number	+ Class

(now go to $43$ )

⁺ See chapter 19 for defined terms.

securities

All entities

Fees

43	Payment method (tick one)
	Invoice
	Electronic payment made Note: Payment may be made electronically if Appendix 3B is given to ASX electronically at the same time
	Periodic payment as agreed with the home branch has been arranged Note: Arrangements can be made for employee incentive schemes that involve frequent issues of securitie

Quotation agreement

• $\mathbf{1}$ *Quotation of our additional *securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
• $\overline{\mathcal{L}}$ We warrant the following to ASX.
• The issue of the *securities to be quoted complies with the law and is not for an illegal purpose.
• There is no reason why those *securities should not be granted *quotation.
• An offer of the ^*securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
• We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the *securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
• If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.

⁺ See chapter 19 for defined terms.

• $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
• We give ASX the information and documents required by this form. If any $\overline{4}$ information or document not available now, will give it to ASX before +quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are true and complete.

Sign here: *

Date: 06/12/06

Director

Print name: Dr Allan Shell

⁺ See chapter 19 for defined terms.